OVERVIEW

Advances in Breast Cancer: Updates from ESMO and San Antonio - Phoenix is organized by Horizon CME and will be held on Jan 30, 2021.

Accreditation:
AMA PRA Category 1 Credit(s)™:
Credit Designation: Horizon CME designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACPE:
This activity has been submitted to the Washington State Pharmacy Association for approval to award up to 5.5 credit hours. The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Learners must attend the entire activity in order to receive ACPE credit. No partial credit will be granted.

Overview:
The management of breast cancer is rapidly changing and increasingly complex due to advances in screening, detection, molecular testing, and treatment including surgery, radiation therapy, and pharmacologic therapies. Advances in Breast Cancer is designed to highlight the latest and most clinically impactful research from major medical conferences.

Expert faculty will review the latest podium research and discuss its application in practice with patient cases. Additionally, a faculty panel will provide perspectives on areas of clinical uncertainty or controversy in the management of breast cancer. This multidisciplinary conference is will assist oncologists, surgeons, radiation oncologists, nurse practitioners, physician assistants, pharmacists, and nurses in translating the latest information to practice in order to optimize care and outcomes for patients with breast cancer.